A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy-Reference-Cited by-同舟云学术

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

Published:2014-07 Issue:7 Volume:25 Page:1333-1339
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gralla R.J.,Bosnjak S.M.,Hontsa A.,Balser C.,Rizzi G.,Rossi G.,Borroni M.E.,Jordan K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/7/1333/19446424/mdu096.pdf

Reference7 articles.

1. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy;De Wit;J Clin Oncol,2003

2. Analysis of cumulative probabilities shows that the efficacy of 5-HT3 antagonist prophylaxis is not maintained;De Wit;J Clin Oncol,1996

3. Pharmacological mechanism of 5-HT3 and tachykinin NK-1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting;Rojas;Eur J Pharmacol,2012

4. Update and new trends in antiemetic therapy: the continuing need for novel therapies;Feyer;Ann Oncol,2011

5. Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study;Hesketh;Ann Oncol,2014

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success;Critical Reviews in Oncology/Hematology;2024-09

2. Antiemetic prophylaxis regimens in haematologic malignancies patients undergoing a hematopoietic stem cell transplantation. Which is the best standard of care? A systematic review;European Journal of Haematology;2024-07-29

3. Real hopes in antiemetic therapy;Meditsinskiy sovet = Medical Council;2024-07-25

4. Exploring the role of ghrelin and des-acyl ghrelin in chemotherapy-induced nausea and vomiting;Neuropharmacology;2024-06

5. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R–CHOP chemotherapy;Scientific Reports;2024-05-16